Supply of asfotase alfa
Originaltitel der Bekanntmachung
Poland – Various medicinal products – DOSTAWA ASFOTAZY ALFA
Opportunity Score
Warum diese Bewertung?
Chance
40 / 100
Komplexität
20 / 100
Risikofaktoren
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of asfotase alfa injection solution (40 mg/ml) in three pack sizes: 0.45 ml (160 packs), 0.7 ml (30 packs), 1.0 ml (60 packs)
- Delivery to University Children's Clinical Hospital in Białystok, Poland
Vollständige Zusammenfassung anzeigen
Open tender for the supply of asfotase alfa (asfotazy alfa) to a children's hospital in Białystok, Poland. Single lot, 24-month contract. Award based solely on lowest price. No estimated value published, but a high bid bond (252,456 PLN) is required. The buyer is a public hospital. EU funding status is inconsistent between structured data (EU-funded) and notice (no EU funds). Eligibility includes pharmaceutical licenses. Only Polish language is accepted.
Risiken
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Bid bond (wadium) of 252,456 PLN required before deadline
Administrative
- Submission via e-ProPublico platform only
- Offer must be signed with qualified electronic signature
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
Białystok, POL
Website
Auftraggeberprofil
Kennung
542-25-34-063
Tätigkeit
Health
Lose (1)
LOT-0001
Supply of asfotase alfa
Delivery of asfotase alfa injection solution in three pack sizes: 40 mg/ml 0.45 ml (160 packs), 0.7 ml (30 packs), and 1.0 ml (60 packs) over 24 months to the University Children's Clinical Hospital in Białystok.
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
Liczba punktów = ( Cmin/Cof ) * 100 * waga gdzie: - Cmin - najniższa cena spośród wszystkich ofert - Cof - cena podana w ofercie
Hinweis zum Wert
Originale TED-Daten anzeigen
Originaler Los-Titel
Dostawa asfotazy alfa
Originale TED-Beschreibung
1 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,45 ml x 12 fiol. OP 160 2 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,7 ml x 12 fiol. OP 30 3 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 1,0 ml x 12 fiol. OP 60
Vergabedetails
- Veröffentlichungsdatum
- 06 Jul 2026
- Sprachen
- Polish
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 466950-2026
Dokumente (1)
Ähnliche Ausschreibungen
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Warum diese Bewertung?
Chance
40 / 100
Komplexität
20 / 100
Risikofaktoren
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications